Field of confusion: future prospects for fibrate therapy in cardiovascular disease.
Rosenson
Robert S
RS
D000368:Aged; D002318:Cardiovascular Diseases / Q000628:therapy*; D002784:Cholesterol / Q000097:blood; D002995:Clofibric Acid / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004311:Double-Blind Method; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D011345:Fenofibrate / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D010919:Placebos; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D010919:Placebos; D014280:Triglycerides; D002995:Clofibric Acid; D002784:Cholesterol; D011345:Fenofibrate